questions for the clever ones here. I'm new to biotechs, so excuse my ignorance.
what type of money values are we looking at for licensing?
did you get a feel that the CellPryme-M technique required specialty (read expensive) equipment to perform(which may also be monetisable) or can it be performed by any lab involved in CAR-T with "standard" CAR-T tech.
DZ
CellPryme-M question, page-8
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $36.23M | |||
| Open | High | Low | Value | Volume |
| 4.4¢ | 4.5¢ | 4.4¢ | $7.345K | 166.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 135418 | 4.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.5¢ | 506903 | 2 |
View Market Depth
| Last trade - 16.10pm 31/05/2024 (20 minute delay) ? |
|
|||||
|
Last
4.5¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 4.5¢ | 4.5¢ | 4.4¢ | 175811 | ||
| Last updated 15.59pm 31/05/2024 ? | |||||
| PTX (ASX) Chart |